OMB control number
The Study to Explore Early Development (SEED) - Phase 3 (Modified for COVID-19 Impact Assessment)
OMB 0920-1171 ยท HHS/CDC.
OMB 0920-1171
SEED is a multi-state case-control study designed to investigate risk factors for Autism Spectrum Disorders (ASDs) and the health and behavioral characteristics of children with ADS. SEED is specifically designed focused on preconception, prenatal, perinatal and early postnatal risk factors with primary emphasis on genetic, infectious, immunological, hormonal, and obstetric risk factors. Due to COVID-19, remote administration and feedback is being proposed in this change request.
The latest form for The Study to Explore Early Development (SEED) - Phase 3 (Modified for COVID-19 Impact Assessment) expires 2021-12-31 and is listed under ICR 202012-0920-003.
Latest Forms, Documents, and Supporting Material
All Historical Document Collections
| Reference | Filing | Received | Concluded | Action |
|---|---|---|---|---|
| 202102-0920-008 | No material or nonsubstantive change to a currently approved collection | 2021-02-18 | Approved without change | |
| 202012-0920-003 | No material or nonsubstantive change to a currently approved collection | 2020-12-08 | Approved with change | |
| 202011-0920-014 | Revision of a currently approved collection | 2020-11-25 | Withdrawn and continue | |
| 202011-0920-002 | No material or nonsubstantive change to a currently approved collection | 2020-11-04 | Approved without change | |
| 202008-0920-014 | No material or nonsubstantive change to a currently approved collection | 2020-08-27 | Approved without change | |
| 201910-0920-002 | Extension without change of a currently approved collection | 2019-10-16 | Approved without change | |
| 201610-0920-010 | New collection (Request for a new OMB Control Number) | 2016-10-31 | Approved with change |
OMB Details
ASD - PRE-ENROLLMENT_Invitation Packet/Response Card (Mother)
Federal Enterprise Architecture: Health - Public Health Monitoring